» Articles » PMID: 2477841

Tenascin, an Extracellular Matrix Protein, Exerts Immunomodulatory Activities

Overview
Specialty Science
Date 1989 Oct 1
PMID 2477841
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Tenascin is a nonubiquitous extracellular matrix protein mainly expressed during morphogenesis in embryonal life. In adults it reappears in malignant tumors and during inflammation and tissue repair. Extracellular matrix proteins can alter cell morphology, adhesion, motility, differentiation, and growth. Since cells of the immune system can express receptors for extracellular matrix, we investigated the effects of tenascin on human monocytes and T and B lymphocytes. Tenascin inhibited monocyte adhesion to fibronectin and enhanced the LFA-1 (lymphocyte function-associated antigen 1)-dependent clustering of Epstein-Barr virus-transformed B cells. The physiological consequences of the effects of tenascin were studied in several T-cell activation models. Tenascin inhibited T-cell activation induced by a soluble antigen (tetanus toxoid), alloantigens, or the mitogen concanavalin A. However, T-cell activation with phytohemagglutinin, crosslinked anti-CD3 antibody, or a mixture of ionomycin and phorbol ester was not inhibited by tenascin. Tenascin did not prevent interleukin 2-dependent T-cell growth or the cytolytic activity of an antigen-specific CD4+ T-cell clone. These results suggest that tenascin alters the adhesion properties of human monocytes, B cells, and T cells. The in vitro immunosuppressive activity of tenascin might be due to abrogation of an accessory cell function at an early stage of the interaction between antigen-presenting cells and T cells.

Citing Articles

FGL1 and FGL2: emerging regulators of liver health and disease.

Chen J, Wu L, Li Y Biomark Res. 2024; 12(1):53.

PMID: 38816776 PMC: 11141035. DOI: 10.1186/s40364-024-00601-0.


Mast cell tolerance in the skin microenvironment to commensal bacteria is controlled by fibroblasts.

Di Nardo A, Chang Y, Alimohammadi S, Masuda-Kuroki K, Wang Z, Sriram K Cell Rep. 2023; 42(5):112453.

PMID: 37120813 PMC: 10290424. DOI: 10.1016/j.celrep.2023.112453.


Characterization of a mGluR5 Knockout Rat Model with Hallmarks of Fragile X Syndrome.

Dahl V, Helmbrecht H, Sigler A, Hildahl K, Sullivan H, Janakiraman S Life (Basel). 2022; 12(9).

PMID: 36143345 PMC: 9504063. DOI: 10.3390/life12091308.


Fibrinogen-like protein 2: Its biological function across cell types and the potential to serve as an immunotherapy target for brain tumors.

Zhang S, Rao G, Heimberger A, Li S Cytokine Growth Factor Rev. 2022; 69:73-79.

PMID: 36085259 PMC: 10204071. DOI: 10.1016/j.cytogfr.2022.08.004.


Genome-scale comparative analysis for host resistance against sea lice between Atlantic salmon and rainbow trout.

Caceres P, Barria A, Christensen K, Bassini L, Correa K, Garcia B Sci Rep. 2021; 11(1):13231.

PMID: 34168167 PMC: 8225872. DOI: 10.1038/s41598-021-92425-3.


References
1.
Norment A, Salter R, Parham P, Engelhard V, Littman D . Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature. 1988; 336(6194):79-81. DOI: 10.1038/336079a0. View

2.
van Noesel C, Miedema F, Brouwer M, de Rie M, Aarden L, van Lier R . Regulatory properties of LFA-1 alpha and beta chains in human T-lymphocyte activation. Nature. 1988; 333(6176):850-2. DOI: 10.1038/333850a0. View

3.
Hemler M . Adhesive protein receptors on hematopoietic cells. Immunol Today. 1988; 9(4):109-13. DOI: 10.1016/0167-5699(88)91280-7. View

4.
Grumet M, Hoffman S, Crossin K, Edelman G . Cytotactin, an extracellular matrix protein of neural and non-neural tissues that mediates glia-neuron interaction. Proc Natl Acad Sci U S A. 1985; 82(23):8075-9. PMC: 391445. DOI: 10.1073/pnas.82.23.8075. View

5.
Ruoslahti E, Hayman E, Pierschbacher M . Extracellular matrices and cell adhesion. Arteriosclerosis. 1985; 5(6):581-94. DOI: 10.1161/01.atv.5.6.581. View